Selected article for: "ACE inhibitor and disease severity"
Author: Khiatah, Bashar; Amos, Amylee; Carlson, Deborah
Title: Association between COVID-19 and angiotensin-converting enzyme inhibitors with the spotlight on zinc: an opinion
  • Cord-id: b8r61fgr
  • Document date: 2021_9_23
    • ID: b8r61fgr
    Snippet: In the setting of the raging COVID-19 pandemic, the search for innovative therapeutics is desperately sought after. As we learn more about the characteristics and metabolic health of patients and as our understanding of COVID-19 pathophysiology and treatment progresses, so is our understanding of medication effects that might increase disease severity. As of late, ACE inhibitors have been under investigation for a potential increase in illness severity due to ACE2 upregulation. Given our knowled
    Document: In the setting of the raging COVID-19 pandemic, the search for innovative therapeutics is desperately sought after. As we learn more about the characteristics and metabolic health of patients and as our understanding of COVID-19 pathophysiology and treatment progresses, so is our understanding of medication effects that might increase disease severity. As of late, ACE inhibitors have been under investigation for a potential increase in illness severity due to ACE2 upregulation. Given our knowledge of other nutrient-pharmaceutical interactions, could the ACE inhibitor impact on COVID be due to something else? In this paper, we discuss the possibility that ACE inhibitors might be affecting COVID-19 patients by causing zinc insufficiency. KEY MESSAGES: 1. Zinc deficiency caused by chronic ACE inhibitor usage may exacerbate the pathogenicity of COVID-19 in susceptible patients. 2. A multi-center study is needed to assess the zinc levels of patients with COVID-19 who are taking ACE inhibitors and other medications that may result in low zinc levels.

    Search related documents:
    Co phrase search for related documents
    • accurate measure and acute respiratory syndrome: 1
    • ace angiotensin convert enzyme and acute respiratory syndrome: 1
    • ace inhibitor and acei angiotensin converting enzyme inhibitor: 1, 2
    • ace inhibitor and acei effect: 1
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acei angiotensin converting enzyme inhibitor and acute ards respiratory distress syndrome: 1
    • acei angiotensin converting enzyme inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5
    • acei effect and acute respiratory syndrome: 1, 2, 3
    • acei sars infection and acute respiratory syndrome: 1, 2
    • acid base balance and acute respiratory syndrome: 1, 2
    • acidic environment and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7